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Blood use in liver transplantation 
"" J. H. LEWIS, F. A. BONTEMPO, F. CORNELL, J. E. KISS, P. LARSON, M. V. RAGNI, E. O. RICE, 
J. A. SPERO, AND T. E. STARZL 
During the first 5 years (1981-1985) of the liver transplantation program in Pittsburgh. a 
total (preoperative. intraoperative. and postoperative) of 18.668 packed red cell units. 
23.627 fresh-frozen plasma units. 20.590 platelet units. and 4241 cryoprecipitate units was 
transfused for the procedures. This represents 3 to 9 percent of the total of blood products 
supplied by the Central Blood Bank to its 32 member hospitals. Six hundred thirty-six 
(636) transplants were performed on 485 patients in two hospitals: the Presbyterian Univer-
sity Hospital (564 beds) and Children's Hospital of Pittsburgh (236 beds). All of the blood 
components used in the operations were procured and released by the Central Blood 
Bank. This report describes some of these findings. TRANSFUSION 1987;27:222-225. 
THE DEVELOPMENT of liver transplantation (LTx) 
programs in recent years has put new demands on 
blood banks and transfusion services, which must 
devise means of coping with this new challenge. The 
Central Blood Bank of Pittsburgh (CBB) provides 
blood product support for 32 member hospitals. Two 
of these hospitals, Presbyterian University Hospital 
(PUH, 564 beds) and Children's Hospital of Pitts-
burgh (CHP, 236 beds) began doing liver transplants 
in 1981. The results of this experiment are reported 
here. 
Study Results 
Figure I divides the numbers of operations done in Pitts-
burgh by I) the year of transplantation, 2) the hospital, and 
3) the number of transplantations per patient. The numbers 
increased almost exponentially. Table I shows that, during 
the first 5 years, 290 adults and 195 children underwent 626 
L Tx. Of these, 61 adults and 54 children received two livers, 
and 15 adults and II children received three livers. 
Table 2 shows the components used preoperatively, 
intraoperatively, and postoperatively. Most packed red cells 
(RBCs) (64%) and cryoprecipitate (86%) were used intraop-
eratively. Slightly more than one-half of the fresh-frozen 
plasma (FFP) and less than one-half of the platelets were 
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used in the operating room. Table 2 also compares the total 
number of components used for LTx with those distributed 
by CBB in the 5 years. The percentages ranged from 3 for 
RBC to 9.2 for FFP. 
Table 3 shows the use of blood components in the two 
hospitals in 1985, the last year of this study. These high 
percentages of blood component use are even more striking 
if the total of 31,000 patient admissions to the two hospitals 
is considered. The patients who had L Tx accounted for less 
than 0.01 percent of admissions, yet used approximately 25 
percent of the blood. 
Figure 2 shows the mean use of blood components in the 
operating room per patient per year. After 1982, there were 
sharp drops in the use of RBC and FFP in adults. The use 
of platelets and cryoprecipitate followed no pattern, and the 
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Table 1. Numbers of liver transplantations 
PUH" 
1; 2 3 
1981 16 1 0 
1982 37 9 0 
1983 47 12 2 
1984 75 13 3 
1985 115 26 10 
Total 290 61 15 
* PUH = Presbyterian University Hospital. 
t CHP = Chlldren's Hospital of Pittsburgh. 
Total 
17 
46 
61 
91 
151 
388 
* Number of liver L Tx performed in reported patients. 
Table 2. Total amounts of blood products (1981-1985) 
for adults and children 
RBC FFP Plat- Cryot 
Preoperative 1546 2572 1098 96 
Intraoperative 12.007 12,884 9420 3640 
Postoperative 5315 8171 10.072 505 
Total 18.868 23.627 20,590 4241 
CBB total units 622.000 256,000 240.000 60,000 
LTx use 3.0 9.2 8.6 7.1 
(% of CBB total) 
* Plat = Platelet units. 
t Cryo = Cryoprecipitate units. 
pediatric operations showed no trend to less use of blood 
components. 
Table 4 shows the decrease in blood use associated with 
second and third L Tx procedures in adults. Blood compo-
nent use in the first L Tx was somewhat higher than that 
shown for all L Tx. Figure 3 shows that, if the interval 
between first and second L Tx in adults was 7 days or less, 
the blood use per patient was roughly one-half (RBC, 8 
units; FFP, 10 units) that of the total for all second L Tx. 
Negligible differences were noted in repeat procedures 
among children who had L Tx. 
Table 5 shows the mean use of "blood" (RBC plus FFP) 
in 229 patients who fell into four of the major diagnostic 
categories: postnecrotic cirrhosis (PNq, primary biliary 
cirrhosis (PBq, sclerosing cholangitis (sq, and carci-
noma/ neoplasia (CA). Because of the dependence on surgi-
CHP-
1f 2 3 Total Total 
9 2 1 12 29· 
29 9 0 38 84-
32 10 2 44 105 
I 59 10 3 72 183 
68 23 5 94 O~ 
195 54 11 260 828 
cal technique and the changes observed by year of surgery, 
the relationship between original diagnosis and blood use is 
difficult to express. It is obvious that in 1985 the PNC 
group that showed the greatest number of coagulation 
abnormalities also used the greatest amount of blood, 
whereas the CA group that showed the most normal 
coagulation patterns used the least blood. 
Discussion 
The preceding findings demonstrate the major 
demands on blood banks in centers where significant 
numbers of L Tx are performed. Early studies from 
this laboratoryl.2 and the data shown in Table 5 sug_· 
gcst that blood use was at least to some extent 
dependent on the basic disease and the severity of 
preoperative coagulation defects. Improvements in 
surgical and anesthcsiologic techniques, intraopera-
tive coagulation monitoring, and therapy of intraop-
erative fibrinolysisl may have contributed to the sub-
stantial drop in blood use per adult patient over the 
period described. Future developments may result in 
further decreases in blood component usage. DuC'to 
the surgical demands for blood and blood compo--
nents (liver transplantation, heart and heart-lung. 
transplantation, etc.), eBB found it necessary to 
import from other blood banks about 2S percent.of 
the blood components used. Autologous intraopcra"': 
tive recovery of blood supplied only a moderate por-
Table 3. Total blood products in units used in each hospital. total used for L Tx. and percentage for L Tx (1985) 
Percentage" 
PUH LTx 
RBC 23152 4318 
FFP 15037 4759 
Platt 23216 4788 
Cryo:j: 2934 1526 
" Percent of use of this component at the institution. 
t Plat = Platelet units. 
* Cryo = Cryoprecipitate units. 
of LTx 
19 
32 
21 
52 
Percentage" 
CHP LTx otlTx-
4142 1093 ~K 
3288 2049 62:, 
4593 2179 4T~ 
1432 229 16"" 
--
---- - --_.-. 
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FIG. 2. Mean units of RBC. FFP. or platelets used per operation 
per year (including second and third L Tx). Plat = platelets. 
Table 4. Blood use in adults (mean 
units/patient/operation) in all procedures and in 
repeat transplantation 
Number of 
procedures RBC FFP Plat' 
All LTx 366 25 24 20 
1st LTx only 290 27 26 20 
2nd LTx only 61 18 18 19 
3rd LTx only 15 17 18 21 
* Plat = Platelet units. 
t Cryo = Cryoprecipitate units. 
Cryot 
9 
10 
8 
9 
tion ofthe demand. For LTx, this may have been due 
in part to the presence of ascites or to the possible 
bacterial contamination of the operative area. Washed 
autologous red cells might have been satisfactory, but 
recovery was slow in the face of frequent large and 
immediate needs. A new pump capable of delivery of 
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FIG. 3. Mean units of RBC and FFP in second L Tx related to 
the interval between first and second L Tx. 
2 I per min4 was life-saving for some patients who 
were near exsanguination. 
Another concern was the possible introduction of 
infectious or viral agents due to the large numbers of 
donor exposures. In 1982, the mean number of expo-
sures per patient was 173 units of blood components; 
in 1983, it was 201. In these years, all blood was tested 
for hepatitis B surface antigen but not for antibodies 
to human immune deficiency virus (HIV) or for 
non-A, non-B (NAN B) hepatitis. If transmission of 
N ANB hepatitis can occur from 5 percentS of donor 
units and HIV from 0.04 percent,6 one would expect 
these transfusion-transmitted infections to be rela-
tively common. Such was not observed, perhaps 
because new hepatitis was masked by the recurrence 
of old hepatitis. Drug-induced (cyclosporine) toxic 
effects on the new livers might also have obscured 
N ANB effects. High-dose immunosuppressive therapy 
mimicked the symptoms of acquired immune defi-
ciency syndrome (AIDS), and the two may not be 
able to be differentiated. In fact, the Centers for 
Disease Control does not recognize a diagnosis of 
AIDS in clinically immunosuppressed patients with 
opportunistic infections. CBB is currently recom-
Table 5. Mean "blood" (RBe + FFP) use in 229 adult patients' divided by diagnostic category and year 
1981 
1982 
1983 
1984 
1985 
Number 
8 
6 
15 
20 
40 
PNCt 
Mean 
78 
136 
90 
47 
37 
, Miscellaneous and fulminant omitted. 
t PNC = Postnecrotic cirrhosis. 
* PBe = Primary biliary cirrhosis. 
§ SC = Sclerosing cholangitis. 
II CA = Carcinoma/neoplasia. 
Number 
1 
11 
11 
13 
43 
Mean 
37 
47 
49 
48 
30 
SCI CAli 
Number Mean Number Mean 
1 16 3 31 
5 92 6 50. 
7 86 7 60 
16 27 6 33 
6 30 4 23 
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mending that modified whole blood (platelet-poor7) 
be su\)stituted for the first to units of both RBC and 
FFP, for a significant decrease in infection exposure. 
In the early phases of the operation, platelets would 
not be added because of their possible thrombogenic 
effects. Coagulation factors in the reconstituted stored 
whole blood would be expected to be somewhat lower 
than in FFP. 
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